Press releases
Read more:
Categories
2021
Nanologica’s drug delivery platforms NLAB Spiro® and NLAB Silica™ consists of nanoporous particles where APIs can be placed inside the...
2021-02-26 08:20
Year-End Report Nanologica 2020
STRONG PERFORMANCE AND INVESTMENTS FOR THE FUTURE 2020 has been a challenging year, but it is with both delight and pride I can look back on the year and...
2021-02-26 08:15
Change in Number of Shares in Nanologica AB
A share-based incentive program of a maximum of 483 883 options was decided by the Annual General Meeting May 31, 2018. The program expires July 1st, 2021...
2021-02-18 08:20
Nanologica Recruits SVP Sales and Senior Advisor for Chromatography
To accelerate sales of chromatography products following the successful upscaling of Nanologica’s silica towards ton scale, Dr. Dutta has been recruited...
2021-01-27 13:34
Nanologica Signs Collaboration Agreement with Zentiva for the use of NLAB Drug Delivery Platforms
The agreement gives Zentiva the right to use the NLAB drug delivery platforms for multiple drug development projects. Project specific agreements will...
2021-01-19 08:34
Nanologica Engages Scientific Advisors within Inhalation
Dr. John Pritchard has more than 40 years of experience from the inhalation industry working in various positions, leading and managing global portfolios...
2020
2020-12-21 08:25
Test Material from Large Scale Production Delivered
Upscaling to large-scale production of Nanologica’s silica started in July 2019. The silica is produced according to Nanologica’s proprietary...
2020-10-30 08:04
Extended Collaboration with Crop Protection Company
Nanologica has signed an agreement for continued collaboration with the global agricultural company that Nanologica has been working with. The extended...
2020-09-30 08:12
Nanologica’s patent granted in Europe
The European Patent Office has granted Nanologica’s patent titled ”A process for manufacturing porous silica particles loaded with at least...